Trinity Biotech Invests in Novus Diagnostics to Accelerate Rapid Sepsis Testing
Trinity Biotech made a strategic investment in Novus Diagnostics to accelerate the development of a 15-minute bedside test for sepsis.
Read MorePosted by Andy Lundin | Nov 27, 2024 | Company News, Sepsis |
Trinity Biotech made a strategic investment in Novus Diagnostics to accelerate the development of a 15-minute bedside test for sepsis.
Read MorePosted by Andy Lundin | Sep 18, 2024 | Diabetes & Metabolic Diseases |
A new study encourages the use of more reliable tests to prevent pregnancy complications and the development of type II diabetes.
Read MorePosted by Andy Lundin | Aug 30, 2024 | Diabetes & Metabolic Diseases |
A blood test measuring IL-6 levels may help identify those with type 2 diabetes who are at high risk of developing obesity-related cancers.
Read MorePosted by Chris Wolski | Aug 12, 2024 | Gastrointestinal Infections |
A partnership aims to offer advanced gut health testing to consumers through retail pharmacies, making these diagnostics more accessible.
Read MorePosted by Andy Lundin | Jul 10, 2024 | Specimen Collection & Handling |
Babson Diagnostics launched a blood testing service that uses a fingertip sample for enhanced convenience, accuracy, and patient experience.
Read More